These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 28495556)
1. Synthesis, crystal structure determination, biological screening and docking studies of N Sultana N; Sarfraz M; Tanoli ST; Akram MS; Sadiq A; Rashid U; Tariq MI Bioorg Chem; 2017 Jun; 72():256-267. PubMed ID: 28495556 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases. Sarfraz M; Sultana N; Rashid U; Akram MS; Sadiq A; Tariq MI Bioorg Chem; 2017 Feb; 70():237-244. PubMed ID: 28126287 [TBL] [Abstract][Full Text] [Related]
3. A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives. Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A Bioorg Med Chem Lett; 2018 Aug; 28(14):2481-2484. PubMed ID: 29887354 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors. Yoon YK; Ali MA; Wei AC; Choon TS; Khaw KY; Murugaiyah V; Osman H; Masand VH Bioorg Chem; 2013 Aug; 49():33-9. PubMed ID: 23886696 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and discovery of highly functionalized mono- and bis-spiro-pyrrolidines as potent cholinesterase enzyme inhibitors. Kia Y; Osman H; Suresh Kumar R; Basiri A; Murugaiyah V Bioorg Med Chem Lett; 2014 Apr; 24(7):1815-9. PubMed ID: 24594354 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases. Saeed A; Mahesar PA; Zaib S; Khan MS; Matin A; Shahid M; Iqbal J Eur J Med Chem; 2014 May; 78():43-53. PubMed ID: 24675179 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives. Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of novel 7-aminoalkyl-substituted flavonoid derivatives with improved cholinesterase inhibitory activities. Luo W; Chen Y; Wang T; Hong C; Chang LP; Chang CC; Yang YC; Xie SQ; Wang CJ Bioorg Med Chem; 2016 Feb; 24(4):672-80. PubMed ID: 26752094 [TBL] [Abstract][Full Text] [Related]
10. Biological Evaluation of Azomethine-dihydroquinazolinone Conjugates as Cancer and Cholinesterase Inhibitors. Iqbal J; Saeed A; Shah SJ; al-Rashida M; Shams-ul Mahmood Med Chem; 2016; 12(1):74-82. PubMed ID: 26152145 [TBL] [Abstract][Full Text] [Related]
11. Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with 'inverted' binding mode. Darras FH; Wehle S; Huang G; Sotriffer CA; Decker M Bioorg Med Chem; 2014 Sep; 22(17):4867-81. PubMed ID: 25047936 [TBL] [Abstract][Full Text] [Related]
12. Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease. Lemes LFN; de Andrade Ramos G; de Oliveira AS; da Silva FMR; de Castro Couto G; da Silva Boni M; Guimarães MJR; Souza INO; Bartolini M; Andrisano V; do Nascimento Nogueira PC; Silveira ER; Brand GD; Soukup O; Korábečný J; Romeiro NC; Castro NG; Bolognesi ML; Romeiro LAS Eur J Med Chem; 2016 Jan; 108():687-700. PubMed ID: 26735910 [TBL] [Abstract][Full Text] [Related]
13. Cholinesterase inhibitory activity versus aromatic core multiplicity: a facile green synthesis and molecular docking study of novel piperidone embedded thiazolopyrimidines. Basiri A; Murugaiyah V; Osman H; Kumar RS; Kia Y; Hooda A; Parsons RB Bioorg Med Chem; 2014 Jan; 22(2):906-16. PubMed ID: 24369842 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological activities of 2,3-dihydroquinazolin-4(1H)-one derivatives as TRPM2 inhibitors. Zhang H; Liu H; Luo X; Wang Y; Liu Y; Jin H; Liu Z; Yang W; Yu P; Zhang L; Zhang L Eur J Med Chem; 2018 May; 152():235-252. PubMed ID: 29723786 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids. Najafi Z; Saeedi M; Mahdavi M; Sabourian R; Khanavi M; Tehrani MB; Moghadam FH; Edraki N; Karimpor-Razkenari E; Sharifzadeh M; Foroumadi A; Shafiee A; Akbarzadeh T Bioorg Chem; 2016 Aug; 67():84-94. PubMed ID: 27289559 [TBL] [Abstract][Full Text] [Related]
17. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease. Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607 [TBL] [Abstract][Full Text] [Related]
18. New cholinesterase inhibitors for Alzheimer's disease: Structure Activity Studies (SARs) and molecular docking of isoquinolone and azepanone derivatives. Bacalhau P; San Juan AA; Marques CS; Peixoto D; Goth A; Guarda C; Silva M; Arantes S; Caldeira AT; Martins R; Burke AJ Bioorg Chem; 2016 Aug; 67():1-8. PubMed ID: 27231829 [TBL] [Abstract][Full Text] [Related]
19. An expedient, ionic liquid mediated multi-component synthesis of novel piperidone grafted cholinesterase enzymes inhibitors and their molecular modeling study. Basiri A; Murugaiyah V; Osman H; Kumar RS; Kia Y; Awang KB; Ali MA Eur J Med Chem; 2013 Sep; 67():221-9. PubMed ID: 23871902 [TBL] [Abstract][Full Text] [Related]
20. Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies. Di Pietro O; Pérez-Areales FJ; Juárez-Jiménez J; Espargaró A; Clos MV; Pérez B; Lavilla R; Sabaté R; Luque FJ; Muñoz-Torrero D Eur J Med Chem; 2014 Sep; 84():107-17. PubMed ID: 25016233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]